BTLA and autoimmune disease: In this study, we aimed to understand the relationship between the constitutively expressed T cell co-inhibitory molecules BTLA [72,73] and CD5, and an induced co-inhibitor, PD-1, in the steady state and under conditions that promote multi-organ autoimmune disease.